Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 453543, 15 pages
http://dx.doi.org/10.1155/2015/453543
Review Article

Probing the Surface of Human Carbonic Anhydrase for Clues towards the Design of Isoform Specific Inhibitors

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, P.O. Box 100245, Gainesville, FL 32610, USA

Received 28 February 2014; Accepted 1 September 2014

Academic Editor: Anna Di Fiore

Copyright © 2015 Melissa A. Pinard et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Domsic, B. S. Avvaru, U. K. Chae et al., “Entrapment of carbon dioxide in the active site of carbonic anhydrase II,” Journal of Biological Chemistry, vol. 283, no. 45, pp. 30766–30771, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. S. Avvaru, C. U. Kim, K. H. Sippel et al., “A short, strong hydrogen bond in the active site of human carbonic anhydrase II,” Biochemistry, vol. 49, no. 2, pp. 249–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Aggarwal, C. D. Boone, B. Kondeti, and R. McKenna, “Structural annotation of human carbonic anhydrases,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 28, no. 2, pp. 267–277, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. M. Krishnamurthy, G. K. Kaufman, A. R. Urbach et al., “Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding,” Chemical Reviews, vol. 108, no. 3, pp. 946–1051, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Květoň, W. R. Chegwidden, N. D. Carter, and Y. H. Edwards, Eds., The Carbonic Anhydrases: New Horizons, vol. 39, Photosynthetica, 2001.
  6. R. S. Rowlett, “Structure and catalytic mechanism of the β-carbonic anhydrases,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1804, no. 2, pp. 362–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. S. Smith and J. G. Ferry, “Prokaryotic carbonic anhydrases,” FEMS Microbiology Reviews, vol. 24, no. 4, pp. 335–366, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. del Prete, D. Vullo, V. de Luca, C. T. Supuran, and C. Capasso, “Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA,” Journal of Enzyme Inhibition and Medicinal Chemistry, 2014. View at Google Scholar
  9. V. Alterio, A. Di Fiore, K. D'Ambrosio, C. T. Supuran, and G. de Simone, “Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?” Chemical Reviews, vol. 112, no. 8, pp. 4421–4468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. C. Frost, “Physiological functions of the alpha class of carbonic anhydrases,” Sub-Cellular Biochemistry, vol. 75, pp. 9–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Aspatwar, M. E. E. Tolvanen, C. Ortutay, and S. Parkkila, “Carbonic anhydrase related protein VIII and its role in neurodegeneration and cancer,” Current Pharmaceutical Design, vol. 16, no. 29, pp. 3264–3276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Eriksson, T. A. Jones, and A. Liljas, “Refined structure of human carbonic anhydrase II at 2.0 Å resolution,” Proteins: Structure, Function and Genetics, vol. 4, no. 4, pp. 274–282, 1988. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Pocker and S. Sarkanen, “Carbonic anhydrase: structure catalytic versatility, and inhibition,” Advances in Enzymology and Related Areas of Molecular Biology, vol. 47, pp. 149–274, 1978. View at Google Scholar · View at Scopus
  14. S. Z. Fisher, C. M. Maupin, M. Budayova-Spano et al., “Atomic crystal and molecular dynamics simulation structures of human carbonic anhydrase II: insights into the proton transfer mechanism,” Biochemistry, vol. 46, no. 11, pp. 2930–2937, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. D. Boone, M. Pinard, R. McKenna, and D. Silverman, “Catalytic mechanism of α-class carbonic anhydrases: CO2 hydration and proton transfer,” Sub-cellular biochemistry, vol. 75, pp. 31–52, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. C. T. Supuran, A. Scozzafava, and A. Casini, “Carbonic anhydrase inhibitors,” Medicinal Research Reviews, vol. 23, no. 2, pp. 146–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Tu, D. N. Silverman, C. Forsman, B.-H. Jonsson, and S. Lindskog, “Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant,” Biochemistry, vol. 28, no. 19, pp. 7913–7918, 1989. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Mikulski, D. West, K. H. Sippel et al., “Water networks in fast proton transfer during catalysis by human carbonic anhydrase II,” Biochemistry, vol. 52, no. 1, pp. 125–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Tu, G. Sanyal, G. C. Wynns, and D. N. Silverman, “The pH dependence of the hydration of CO2 catalyzed by carbonic anhydrase III from skeletal muscle of the cat. Steady state and equilibrium studies,” The Journal of Biological Chemistry, vol. 258, no. 14, pp. 8867–8871, 1983. View at Google Scholar · View at Scopus
  20. H. An, C. Tu, D. Duda et al., “Chemical rescue in catalysis by human carbonic anhydrases II and III,” Biochemistry, vol. 41, no. 9, pp. 3235–3242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. D. N. Silverman, C. K. Tu, and G. C. Wynns, “Role of buffer in catalysis of the hydration of CO2 by carbonic anhydrase,” in Biophysics and Physiology of Carbon Dioxide, P. D. C. Bauer, P. D. G. Gros, and P. D. H. Bartels, Eds., pp. 254–61, Springer, Berlin, Germany, 1980. View at Google Scholar
  22. R. McKenna and C. T. Supuran, “Carbonic anhydrase inhibitors drug design,” Sub-Cellular Biochemistry, vol. 75, pp. 291–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. H. Maren and E. R. Swenson, “A comparative study of the kinetics of the Bohr effect in vertebrates,” Journal of Physiology, vol. 303, pp. 535–547, 1980. View at Google Scholar · View at Scopus
  24. D. Brown, T. Kumpulainen, J. Roth, and L. Orci, “Immunohistochemical localization of carbonic anhydrase in postnatal and adult rat kidney,” The American Journal of Physiology, vol. 245, no. 1, pp. F110–F118, 1983. View at Google Scholar · View at Scopus
  25. K. M. Gilmour, “Perspectives on carbonic anhydrase,” Comparative Biochemistry and Physiology: A Molecular and Integrative Physiology, vol. 157, no. 3, pp. 193–197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. W. Vince and R. A. Reithmeier, “Carbonic anhydrase II binds to the carboxyl terminus of human band 3, the erythrocyte C1-/HCO3- exchanger,” The Journal of Biological Chemistry, vol. 273, no. 43, pp. 28430–28437, 1998. View at Google Scholar
  27. A. Pushkin, N. Abuladze, E. Gross et al., “Molecular mechanism of kNBC1—carbonic anhydrase II interaction in proximal tubule cells,” The Journal of Physiology, vol. 559, no. 1, pp. 55–65, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Li, B. Alvarez, J. R. Casey, R. A. F. Reithmeier, and L. Fliegel, “Carbonic anhydrase II binds to and enhances activity of the Na+/H+ exchanger,” The Journal of Biological Chemistry, vol. 277, no. 39, pp. 36085–36091, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. H. L. McMurtrie, H. J. Cleary, B. V. Alvarez et al., “The bicarbonate transport metabolon,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 19, no. 3, pp. 231–236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. W. S. Sly, D. Hewett-Emmett, M. P. Whyte, Y. S. Yu, and R. E. Tashian, “Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 9, pp. 2752–2756, 1983. View at Publisher · View at Google Scholar · View at Scopus
  31. R. P. Henry and E. R. Swenson, “The distribution and physiological significance of carbonic anhydrase in vertebrate gas exchange organs,” Respiration Physiology, vol. 121, no. 1, pp. 1–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. G. J. Cooper and W. F. Boron, “Effect of PCMBS on CO2 permeability of xenopus oocytes expressing aquaporin 1 or its C189S mutant,” The American Journal of Physiology, vol. 275, no. 6, pp. C1481–C1486, 1998. View at Google Scholar · View at Scopus
  33. N. D. Carter, “Hormonal and neuronal control of carbonic anhydrase III gene expression in skeletal muscle,” in The Carbonic Anhydrases: Cellular Physiology and Molecular Genetics, S. J. Dodgson, R. E. Tashian, G. Gross, and N. D. Carter, Eds., pp. 247–256, Plenum Press, New York, NY, USA, 1991. View at Google Scholar
  34. L. W. Stanton, P. A. Ponte, R. T. Coleman, and M. A. Snyder, “Expression of CA III in rodent models of obesity,” Molecular Endocrinology, vol. 5, no. 6, pp. 860–866, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. G. E. Lyons, M. E. Buckingham, S. Tweedie, and Y. H. Edwards, “Carbonic anhydrase III, an early mesodermal marker, is expressed in embryonic mouse skeletal muscle and notochord,” Development, vol. 111, no. 1, pp. 233–244, 1991. View at Google Scholar · View at Scopus
  36. C. T. Supuran, “Carbonic anhydrases—an overview,” Current Pharmaceutical Design, vol. 14, no. 7, pp. 603–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. Y.-C. Chai, C.-H. Jung, C.-K. Lii et al., “Identification of an abundant S-thiolated rat liver protein as carbonic anhydrase III; characterization of S-thiolation and dethiolation reactions,” Archives of Biochemistry and Biophysics, vol. 284, no. 2, pp. 270–278, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. M. C. Mitterberger, G. Kim, U. Rostek, R. L. Levine, and W. Zwerschke, “Carbonic anhydrase III regulates peroxisome proliferator-activated receptor-γ2,” Experimental Cell Research, vol. 318, no. 8, pp. 877–886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Bootorabi, J. Jänis, E. Smith et al., “Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme,” Biochimie, vol. 92, no. 8, pp. 1072–1080, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Truppo, C. T. Supuran, A. Sandomenico et al., “Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 4, pp. 1560–1564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Thiry, J.-M. Dogné, C. T. Supuran, and B. Masereel, “Carbonic anhydrase inhibitors as anticonvulsant agents,” Current Topics in Medicinal Chemistry, vol. 7, no. 9, pp. 855–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Ruusuvuori, H. Li, K. Huttu et al., “Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells,” The Journal of Neuroscience, vol. 24, no. 11, pp. 2699–2707, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Asiedu, M. H. Ossipov, K. Kaila, and T. J. Price, “Acetazolamide and midazolam act synergistically to inhibit neuropathic pain,” Pain, vol. 148, no. 2, pp. 302–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Lehtonen, B. Shen, M. Vihinen et al., “Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family,” Journal of Biological Chemistry, vol. 279, no. 4, pp. 2719–2727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Kummola, J. M. Hämäläinen, J. Kivelä et al., “Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa,” BMC Cancer, vol. 5, article 41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. G. N. Shah, D. Hewett-Emmett, J. H. Grubb et al., “Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from chose of CA VA suggest distinct physiological roles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1677–1682, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. C. J. Lusty, “Carbamyl phosphate synthetase. Bicarbonate-dependent hydrolysis of ATP and potassium activation,” The Journal of Biological Chemistry, vol. 253, no. 12, pp. 4270–4278, 1978. View at Google Scholar · View at Scopus
  48. S. J. Dodgson and R. E. Forster II, “Inhibition of CA V decreases glucose synthesis from pyruvate,” Archives of Biochemistry and Biophysics, vol. 251, no. 1, pp. 198–204, 1986. View at Publisher · View at Google Scholar · View at Scopus
  49. C. J. Lynch, H. Fox, S. A. Hazen, B. A. Stanley, S. Dodgson, and K. F. Lanoue, “Role of hepatic carbonic anhydrase in de novo lipogenesis,” Biochemical Journal, vol. 310, part 1, pp. 197–202, 1995. View at Google Scholar · View at Scopus
  50. K. J. Oommen and S. Mathews, “Zonisamide: a new antiepileptic drug,” Clinical Neuropharmacology, vol. 22, no. 4, pp. 192–200, 1999. View at Google Scholar · View at Scopus
  51. Y. Ogawa, K. Matsumoto, T. Maeda et al., “Characterization of lacrimal gland carbonic anhydrase VI,” Journal of Histochemistry and Cytochemistry, vol. 50, no. 6, pp. 821–827, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. J. S. Leinonen, K. A. Saari, J. M. Seppänen, H. M. Myllylä, and H. J. Rajaniemi, “Immunohistochemical demonstration of carbonic anhydrase isoenzyme VI (CA VI) expression in rat lower airways and lung,” Journal of Histochemistry and Cytochemistry, vol. 52, no. 8, pp. 1107–1112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Kaseda, N. Ichihara, T. Nishita, H. Amasaki, and M. Asari, “Immunohistochemistry of the bovine secretory carbonic anhydrase isozyme (CA-VI) in bovine alimentary canal and major salivary glands,” Journal of Veterinary Medical Science, vol. 68, no. 2, pp. 131–135, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. C. E. Smith, A. Nanci, and P. Moffatt, “Evidence by signal peptide trap technology for the expression of carbonic anhydrase 6 in rat incisor enamel organs,” European Journal of Oral Sciences, vol. 114, supplement 1, pp. 147–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Breiner Feldstein and D. N. Silverman, “Purification and characterization of carbonic anhydrase from the saliva of the rat,” Journal of Biological Chemistry, vol. 259, no. 9, pp. 5447–5453, 1984. View at Google Scholar · View at Scopus
  56. J. A. Ship, “Diabetes and oral health: an overview,” Journal of the American Dental Association (1939), vol. 134, Spec No:4S–10S, 2003. View at Google Scholar · View at Scopus
  57. F. J. Dowd, “Saliva and dental caries,” Dental clinics of North America, vol. 43, no. 4, pp. 579–597, 1999. View at Google Scholar · View at Scopus
  58. M. Kimoto, M. Kishino, Y. Yura, and Y. Ogawa, “A role of salivary carbonic anhydrase VI in dental plaque,” Archives of Oral Biology, vol. 51, no. 2, pp. 117–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. Ortho-McNeil-Janssen Pharmaceuticals I, Topomax: drug summary, physicians’ desk reference, 2013.
  60. A. R. Shatzman and R. I. Henkin, “Gustin concentration changes relative to salivary zinc and taste in humans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 6 I, pp. 3867–3871, 1981. View at Publisher · View at Google Scholar · View at Scopus
  61. X. L. Zhu and W. S. Sly, “Carbonic anhydrase IV from human lung. Purification, characterization, and comparison with membrane carbonic anhydrase from human kidney,” Journal of Biological Chemistry, vol. 265, no. 15, pp. 8795–8801, 1990. View at Google Scholar · View at Scopus
  62. Z. Yang, B. V. Alvarez, C. Chakarova et al., “Mutant carbonic anhydrase 4 impairs pH regulation and causes retinal photoreceptor degeneration,” Human Molecular Genetics, vol. 14, no. 2, pp. 255–265, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Rebello, R. Ramesar, A. Vorster et al., “Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosa,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 17, pp. 6617–6622, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Ivanov, S.-Y. Liao, A. Ivanova et al., “Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer,” American Journal of Pathology, vol. 158, no. 3, pp. 905–919, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Pastoreková, S. Parkkila, A.-K. Parkkila et al., “Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts,” Gastroenterology, vol. 112, no. 2, pp. 398–408, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Lou, P. C. McDonald, A. Oloumi et al., “Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors,” Cancer Research, vol. 71, pp. 3364–3376, 2011. View at Google Scholar
  67. P. Swietach, A. Hulikova, R. D. Vaughan-Jones, and A. L. Harris, “New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation,” Oncogene, vol. 29, no. 50, pp. 6509–6521, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Parkkila, H. Rajaniemi, A.-K. Parkkila et al., “Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2220–2224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Robertson, C. Potter, and A. L. Harris, “Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion,” Cancer Research, vol. 64, no. 17, pp. 6160–6165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Švastová, N. Žilka, M. Zat'ovičová et al., “Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with β-catenin,” Experimental Cell Research, vol. 290, no. 2, pp. 332–345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. C. C. Wykoff, N. J. P. Beasley, P. H. Watson et al., “Hypoxia-inducible expression of tumor-associated carbonic anhydrases,” Cancer Research, vol. 60, no. 24, pp. 7075–7083, 2000. View at Google Scholar · View at Scopus
  72. S. K. Chia, C. C. Wykoff, P. H. Watson et al., “Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma,” The American Society of Clinical Oncology: Journal of Clinical Oncology, vol. 19, no. 16, pp. 3660–3668, 2001. View at Google Scholar · View at Scopus
  73. D. Generali, S. B. Fox, A. Berruti et al., “Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer,” Endocrine-Related Cancer, vol. 13, no. 3, pp. 921–930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. C. J. Creighton, K. E. Cordero, J. M. Larios et al., “Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors,” Genome Biology, vol. 7, no. 4, article R28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Nordfors, J. Haapasalo, M. Korja et al., “The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis,” BMC Cancer, vol. 10, article 148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. M. I. Ilie, V. Hofman, C. Ortholan et al., “Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis,” International Journal of Cancer, vol. 128, no. 7, pp. 1614–1623, 2011. View at Publisher · View at Google Scholar · View at Scopus
  77. M.-H. Chien, T.-H. Ying, Y.-H. Hsieh et al., “Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis,” Oral Oncology, vol. 48, no. 5, pp. 417–423, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Parkkila, H. Rajaniemi, A.-K. Parkkila et al., “Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2220–2224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Hynninen, S. Parkkila, H. Huhtala et al., “Carbonic anhydrase isozymes II, IX, and XII in uterine tumors,” APMIS, vol. 120, no. 2, pp. 117–129, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Kivela, S. Parkkila, J. Saarnio et al., “Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors,” The American Journal of Pathology, vol. 156, no. 2, pp. 577–584, 2000. View at Publisher · View at Google Scholar · View at Scopus
  81. E. Muhammad, N. Leventhal, G. Parvari et al., “Autosomal recessive hyponatremia due to isolated salt wasting in sweat associated with a mutation in the active site of Carbonic Anhydrase 12,” Human Genetics, vol. 129, no. 4, pp. 397–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. K. Fujikawa-Adachi, I. Nishimori, T. Taguchi, and S. Onishi, “Human carbonic anhydrase XIV (CA14): cDNA cloning, mRNA expression, and mapping to chromosome 1,” Genomics, vol. 61, no. 1, pp. 74–81, 1999. View at Publisher · View at Google Scholar · View at Scopus
  83. J. D. Ochrietor, M. F. Clamp, T. P. Moroz et al., “Carbonic anhydrase XIV identified as the membrane CA in mouse retina: strong expression in Müller cells and the RPE,” Experimental Eye Research, vol. 81, no. 4, pp. 492–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Kaunisto, S. Parkkila, H. Rajaniemi, A. Waheed, J. Grubb, and W. S. Sly, “Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification,” Kidney International, vol. 61, no. 6, pp. 2111–2118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. C. Juel, C. Lundby, M. Sander, J. A. L. Calbet, and G. van Hall, “Human skeletal muscle and erythrocyte proteins involved in acid-base homeostasis: adaptations to chronic hypoxia,” Journal of Physiology, vol. 548, no. 2, pp. 639–648, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. L. A. Vargas and B. V. Alvarez, “Carbonic anhydrase XIV in the normal and hypertrophic myocardium,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 3, pp. 741–752, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Linser and A. A. Moscona, “Variable CA II compartmentalization in vertebrate retina,” Annals of the New York Academy of Sciences, vol. 429, pp. 430–446, 1984. View at Publisher · View at Google Scholar · View at Scopus
  88. C. T. Supuran, “Carbonic anhydrases: novel therapeutic applications for inhibitors and activators,” Nature Reviews Drug Discovery, vol. 7, no. 2, pp. 168–181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. C. T. Supuran, “Carbonic anhydrase inhibitors: an editorial,” Expert Opinion on Therapeutic Patents, vol. 23, no. 6, pp. 677–679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Eichhorn, “Mode of action, clinical profile and relevance of carbonic anhydrase inhibitors in glaucoma therapy,” Klinische Monatsblatter fur Augenheilkunde, vol. 230, no. 2, pp. 146–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. I. Nishimori, D. Vullo, A. Innocenti, A. Scozzafava, A. Mastrolorenzo, and C. T. Supuran, “Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors,” Journal of Medicinal Chemistry, vol. 48, no. 24, pp. 7860–7866, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. I. Nishimori, T. Minakuchi, S. Onishi, D. Vullo, A. Scozzafava, and C. T. Supuran, “Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors,” Journal of Medicinal Chemistry, vol. 50, no. 2, pp. 381–388, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. E. S. Pilka, G. Kochan, U. Oppermann, and W. W. Yue, “Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development,” Biochemical and Biophysical Research Communications, vol. 419, no. 3, pp. 485–489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Vullo, J. Voipio, A. Innocenti et al., “Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides,” Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 4, pp. 971–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Gao, S. Liao, C. Zhang et al., “Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship,” European Journal of Medicinal Chemistry, vol. 62, pp. 597–604, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. D. A. Whittington, A. Waheed, B. Ulmasov et al., “Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, pp. 9545–9550, 2001. View at Publisher · View at Google Scholar · View at Scopus
  97. D. A. Whittington, J. H. Grubb, A. Waheed, G. N. Shah, W. S. Sly, and D. W. Christianson, “Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV: implications for selective inhibition of membrane-associated isozymes,” The Journal of Biological Chemistry, vol. 279, no. 8, pp. 7223–7228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  98. J. D. Thompson, D. G. Higgins, and T. J. Gibson, “CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Research, vol. 22, no. 22, pp. 4673–4680, 1994. View at Publisher · View at Google Scholar · View at Scopus
  99. M. A. Larkin, G. Blackshields, N. P. Brown et al., “Clustal W and Clustal X version 2.0,” Bioinformatics, vol. 23, no. 21, pp. 2947–2948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. P. Emsley and K. Cowtan, “Coot: model-building tools for molecular graphics,” Acta Crystallographica Section D: Biological Crystallography, vol. 60, no. 1, pp. 2126–2132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.n.d.
  102. J. Kyte and R. F. Doolittle, “A simple method for displaying the hydropathic character of a protein,” Journal of Molecular Biology, vol. 157, no. 1, pp. 105–132, 1982. View at Publisher · View at Google Scholar · View at Scopus
  103. A. J. Esbaugh and B. L. Tufts, “The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates,” Respiratory Physiology and Neurobiology, vol. 154, no. 1-2, pp. 185–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. E. R. Swenson, “Respiratory and renal roles of carbonic anhydrase in gas exchange and acid-base regulation,” EXS, no. 90, pp. 281–341, 2000. View at Google Scholar · View at Scopus
  105. M. A. Pinard, C. D. Boone, B. D. Rife, C. T. Supuran, and R. McKenna, “Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases,” Bioorganic and Medicinal Chemistry, vol. 21, no. 22, pp. 7210–7215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Aggarwal, B. Kondeti, and R. McKenna, “Insights towards sulfonamide drug specificity in α-carbonic anhydrases,” Bioorganic and Medicinal Chemistry, vol. 21, no. 6, pp. 1526–1533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Lindskog, “Structure and mechanism of Carbonic Anhydrase,” Pharmacology and Therapeutics, vol. 74, no. 1, pp. 1–20, 1997. View at Publisher · View at Google Scholar · View at Scopus
  108. C. T. Supuran and J.-Y. Winum, Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications, John Wiley & Sons, 2009.
  109. C. Temperini, A. Scozzafava, and C. T. Supuran, “Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct—an inhibitor mimicking the sulfonamide and urea binding to the enzyme,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 2, pp. 474–478, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. B. M. Jönsson, K. Håkansson, and A. Liljas, “The structure of human carbonic anhydrase II in complex with bromide and azide,” FEBS Letters, vol. 322, no. 2, pp. 186–190, 1993. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Mangani and K. Håkansson, “Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions,” European Journal of Biochemistry, vol. 210, no. 3, pp. 867–871, 1992. View at Publisher · View at Google Scholar · View at Scopus
  112. K. Hakansson, M. Carlsson, L. A. Svensson, and A. Liljas, “Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes,” Journal of Molecular Biology, vol. 227, no. 4, pp. 1192–1204, 1992. View at Publisher · View at Google Scholar · View at Scopus
  113. C. T. Supuran and A. Scozzafava, “Carbonic-anhydrase inhibitors and their therapeutic potential,” Expert Opinion on Therapeutic Patents, vol. 10, no. 5, pp. 575–600, 2000. View at Publisher · View at Google Scholar · View at Scopus
  114. S. K. Nair, P. A. Ludwig, and D. W. Christianson, “Two-site binding of phenol in the active site of human carbonic anhydrase II: structural implications for substrate association,” Journal of the American Chemical Society, vol. 116, no. 8, pp. 3659–3660, 1994. View at Publisher · View at Google Scholar · View at Scopus
  115. Dictionary of Natural Products (DVD), vol. version 21.1., CRC & Taylor & Francis, 2012.
  116. A. Maresca, C. Temperini, H. Vu et al., “Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors,” Journal of the American Chemical Society, vol. 131, no. 8, pp. 3057–3062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Maresca, C. Temperini, L. Pochet, B. Masereel, A. Scozzafava, and C. T. Supuran, “Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins,” Journal of Medicinal Chemistry, vol. 53, no. 1, pp. 335–344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. F. Carta, C. Temperini, A. Innocenti, A. Scozzafava, K. Kaila, and C. T. Supuran, “Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule,” Journal of Medicinal Chemistry, vol. 53, no. 15, pp. 5511–5522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. M. Lopez, B. Paul, A. Hofmann et al., “S-glycosyl primary sulfonamides—a new structural class for selective inhibition of cancer-associated carbonic anhydrases,” Journal of Medicinal Chemistry, vol. 52, no. 20, pp. 6421–6432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. O. M. Rodríguez, A. Maresca, C. A. Témpera, R. D. Bravo, P. A. Colinas, and C. T. Supuran, “N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 15, pp. 4447–4450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Lopez, J. Trajkovic, L. F. Bornaghi et al., “Design, synthesis, and biological evaluation of novel carbohydrate-based sulfamates as carbonic anhydrase inhibitors,” Journal of Medicinal Chemistry, vol. 54, no. 5, pp. 1481–1489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. L. L. Woo, A. Purohit, B. Malini, M. J. Reed, and B. V. Potter, “Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates,” Chemistry & Biology, vol. 7, no. 10, pp. 773–791, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Askoxylakis, R. Garcia-Boy, S. Rana et al., “A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology,” PLoS ONE, vol. 5, no. 12, Article ID e15962, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. Y. Li, H. Wang, E. Oosterwijk et al., “Antibody-specific detection of CAIX in breast and prostate cancers,” Biochemical and Biophysical Research Communications, vol. 386, no. 3, pp. 488–492, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Dekaminaviciute, V. Kairys, M. Zilnyte et al., “Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity,” Journal of Enzyme Inhibition and Medicinal Chemistry, 2014. View at Google Scholar
  126. F. Carta, M. Aggarwal, A. Maresca, A. Scozzafava, R. McKenna, and C. T. Supuran, “Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations,” Chemical Communications, vol. 48, no. 13, pp. 1868–1870, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Carta, M. Aggarwal, A. Maresca et al., “Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo,” Journal of Medicinal Chemistry, vol. 55, no. 4, pp. 1721–1730, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. E. Bayram, M. Senturk, O. Irfan Kufrevioglu, and C. T. Supuran, “In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II,” Bioorganic and Medicinal Chemistry, vol. 16, no. 20, pp. 9101–9105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. F. Carta, A. Maresca, A. Scozzafava, and C. T. Supuran, “Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII,” Bioorganic and Medicinal Chemistry, vol. 20, no. 7, pp. 2266–2273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. F. Carta, D. Vullo, A. Maresca, A. Scozzafava, and C. T. Supuran, “New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 6, pp. 2182–2185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. A. Maresca and C. T. Supuran, “Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones i and II,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 15, pp. 4511–4514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. A. Maresca, A. Scozzafava, and C. T. Supuran, “7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones i and II in the low nanomolar/subnanomolar range,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 24, pp. 7255–7258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. R. A. Davis, D. Vullo, A. Maresca, C. T. Supuran, and S.-A. Poulsen, “Natural product coumarins that inhibit human carbonic anhydrases,” Bioorganic and Medicinal Chemistry, vol. 21, no. 6, pp. 1539–1543, 2013. View at Publisher · View at Google Scholar · View at Scopus
  134. F. Carta, A. Maresca, A. Scozzafava, and C. T. Supuran, “5- and 6-Membered (thio)lactones are prodrug type carbonic anhydrase inhibitors,” Bioorganic and Medicinal Chemistry Letters, vol. 22, no. 1, pp. 267–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. K. Tars, D. Vullo, A. Kazaks et al., “Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases,” Journal of Medicinal Chemistry, vol. 56, no. 1, pp. 293–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  136. K. H. Sippel, A. Stander, C. Tu et al., “Characterization of carbonic anhydrase isozyme specific inhibition by sulfamated 2-ethylestra compounds,” Letters in Drug Design and Discovery, vol. 8, no. 8, pp. 678–684, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. B. A. Stander, F. Joubert, C. Tu, K. H. Sippel, R. McKenna, and A. M. Joubert, “In vitro evaluation of ESE-15-ol, an estradiol analogue with nanomolar antimitotic and carbonic anhydrase inhibitory activity,” PLoS ONE, vol. 7, no. 12, Article ID e52205, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. G. de Simone and C. T. Supuran, “Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target,” Biochimica et Biophysica Acta, vol. 1804, no. 2, pp. 404–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. J. Závada, Z. Závadová, J. Pastorek, Z. Biesovä, J. Ježek, and J. Velek, “Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion,” British Journal of Cancer, vol. 82, no. 11, pp. 1808–1813, 2000. View at Publisher · View at Google Scholar · View at Scopus
  140. P. Buanne, G. Renzone, F. Monteleone et al., “Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells,” Journal of Proteome Research, vol. 12, no. 1, pp. 282–292, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. D. M. Duda, C. Tu, S. Z. Fisher et al., “Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer,” Biochemistry, vol. 44, no. 30, pp. 10046–10053, 2005. View at Publisher · View at Google Scholar · View at Scopus
  142. A. Casini, A. Scozzafava, F. Mincione, L. Menabuoni, M. A. Ilies, and C. T. Supuran, “Carbonic anhydrase inhibitors: Water-soluble 4-sulfamoylphenylthioureas as topical intraocular pressure-lowering agents with long-lasting effects,” Journal of Medicinal Chemistry, vol. 43, no. 25, pp. 4884–4892, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. A. Scozzafava, L. Menabuoni, F. Mincione, and C. T. Supuran, “Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties,” Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 1466–1476, 2002. View at Publisher · View at Google Scholar · View at Scopus